Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sufentanil maternal and fetal pharmacokinetics after intra-amniotic injection
2015-001721-16Phase 2Completed
- Sponsor
- CHU de Lille
- Start
- Jul 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sufentanil, sponsored by CHU de Lille. Primary endpoint: Morphine derivatives fetal plasma concentrations. Started Jul 2015; status: completed.
02
Drugs
sufentanil
Beyond the preview
Go deeper on 2015-001721-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001721-16.